Muhammad A. Eldeen

Zagazig, SHR 44519, Egypt

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 27 publications

Enhancing Exercise Performance with Natural Products: A Comprehensive Review.

Enhancing Exercise Performance with Natural Products: A Comprehensive Review.

Journal: Nutrients

Published: May 07, 2026

Integrated pan-cancer multi-omics profiling and experimental validation identify LSM12 as a prognostic biomarker and candidate therapeutic target in human cancers.

Integrated pan-cancer multi-omics profiling and experimental validation identify LSM12 as a prognostic biomarker and candidate therapeutic target in human cancers.

Journal: BMC cancer

Published: March 05, 2026

Correction: Oncogenic EME1 promotes tumor progression and immune modulation in human cancers with therapeutic targeting potential.

Correction: Oncogenic EME1 promotes tumor progression and immune modulation in human cancers with therapeutic targeting potential.

Journal: Discover oncology

Published: October 23, 2025

Physalis peruviana and Lactobacillus lysates as modulators of lipid metabolism and oxidative stress: a natural alternative to statin therapy.

Physalis peruviana and Lactobacillus lysates as modulators of lipid metabolism and oxidative stress: a natural alternative to statin therapy.

Journal: Folia microbiologica

Published: August 19, 2025

Oncogenic EME1 promotes tumor progression and immune modulation in human cancers with therapeutic targeting potential.

Oncogenic EME1 promotes tumor progression and immune modulation in human cancers with therapeutic targeting potential.

Journal: Discover oncology

Published: May 28, 2025

Antioxidant activity of 2-mercaptoethanol protects against CD8+ T cell overstimulation or accelerated exhaustion: evidence from an in vitro exhausted CD8+ T model and in vivo adoptive cell transfer.

Antioxidant activity of 2-mercaptoethanol protects against CD8+ T cell overstimulation or accelerated exhaustion: evidence from an in vitro exhausted CD8+ T model and in vivo adoptive cell transfer.

Journal: International immunopharmacology

Published: May 15, 2025

ALG3 as a PanCancer Oncogene: Bioinformatics Analysis and Identification of Small-Molecule Inhibitors.

ALG3 as a PanCancer Oncogene: Bioinformatics Analysis and Identification of Small-Molecule Inhibitors.

Journal: Anti-cancer agents in medicinal chemistry

Published: April 21, 2025

Beyond Skin Deep: Phospholipid-Based Nanovesicles as Game-Changers in Transdermal Drug Delivery.

Beyond Skin Deep: Phospholipid-Based Nanovesicles as Game-Changers in Transdermal Drug Delivery.

Journal: AAPS PharmSciTech

Published: April 28, 2024

Unraveling Extremely Damaging IRAK4 Variants and Their Potential Implications for IRAK4 Inhibitor Efficacy.

Unraveling Extremely Damaging IRAK4 Variants and Their Potential Implications for IRAK4 Inhibitor Efficacy.

Journal: Journal of personalized medicine

Published: October 02, 2023

A Comprehensive Pan-Cancer Analysis Identifies CEP55 as a Potential Oncogene and Novel Therapeutic Target.

A Comprehensive Pan-Cancer Analysis Identifies CEP55 as a Potential Oncogene and Novel Therapeutic Target.

Journal: Diagnostics (Basel, Switzerland)

Published: February 25, 2023

Integration of Chemoinformatics and Multi-Omics Analysis Defines ECT2 as a Potential Target for Cancer Drug Therapy.

Integration of Chemoinformatics and Multi-Omics Analysis Defines ECT2 as a Potential Target for Cancer Drug Therapy.

Journal: Biology

Published: February 20, 2023

Identification of a Potential Vaccine against Treponema pallidum Using Subtractive Proteomics and Reverse-Vaccinology Approaches.

Identification of a Potential Vaccine against Treponema pallidum Using Subtractive Proteomics and Reverse-Vaccinology Approaches.

Journal: Vaccines

Published: October 28, 2022

Showing 1-12 of 27

Last Updated: 09/26/2026